What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Antibody, Molecular biology, Proteomics, Proteome and Monoclonal antibody.
His work carried out in the field of Antibody brings together such families of science as Bacteriophage and Antigen.
His Molecular biology study combines topics from a wide range of disciplines, such as Cell culture, Biochemistry, Immunoglobulin light chain, Molecular cloning and Hybridoma technology.
His research integrates issues of Cancer, Adenocarcinoma, Analyte and Bioinformatics in his study of Proteomics.
His studies deal with areas such as DNA microarray, Computational biology and Antibody microarray as well as Proteome.
His Monoclonal antibody research includes elements of Epitope, Immunization and Virology.
His most cited work include:
- Method of producing human monoclonal antibodies and kit therefor (528 citations)
- Recombining germline-derived CDR sequences for creating diverse single- framework antibody libraries (375 citations)
- Antibodies in diagnostics – from immunoassays to protein chips (253 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Antibody, Molecular biology, Computational biology, Immunology and DNA microarray.
His studies examine the connections between Antibody and genetics, as well as such issues in Antigen, with regards to In vivo.
His Molecular biology course of study focuses on CD40 and Antigen-presenting cell and Cell biology.
The various areas that Carl A.K. Borrebaeck examines in his DNA microarray study include Microarray, Proteome, Proteomics and Analyte.
His Proteomics study combines topics in areas such as Antibody microarray, Cancer and Bioinformatics.
His work deals with themes such as Immunoglobulin light chain and Immunization, which intersect with Monoclonal antibody.
He most often published in these fields:
- Antibody (35.60%)
- Molecular biology (32.31%)
- Computational biology (19.56%)
What were the highlights of his more recent work (between 2011-2021)?
- Antibody (35.60%)
- Internal medicine (6.59%)
- Proteomics (14.07%)
In recent papers he was focusing on the following fields of study:
Carl A.K. Borrebaeck mainly focuses on Antibody, Internal medicine, Proteomics, Computational biology and Oncology.
His work in Antibody addresses issues such as Antigen, which are connected to fields such as Prostate cancer.
His Internal medicine research is multidisciplinary, relying on both Gene expression and Pathology.
His study in Proteomics is interdisciplinary in nature, drawing from both Proteome, Multiplex, Bioinformatics, Antibody microarray and DNA microarray.
In his work, Phage display is strongly intertwined with Molecular biology, which is a subfield of Computational biology.
His Oncology study also includes
- Pancreatic cancer that intertwine with fields like Cohort, Disease and Carcinoma,
- Biomarker, which have a strong connection to Immunology, Immune system, Sample and Pancreatitis.
Between 2011 and 2021, his most popular works were:
- Precision diagnostics : moving towards protein biomarker signatures of clinical utility in cancer (155 citations)
- Identification of Serum Biomarker Signatures Associated with Pancreatic Cancer (83 citations)
- The GARD assay for assessment of chemical skin sensitizers (66 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Proteomics, Biomarker, Antibody, Oncology and Internal medicine.
The concepts of his Proteomics study are interwoven with issues in Proteome, Multiplex, Bioinformatics, DNA microarray and Computational biology.
His DNA microarray research incorporates elements of Antibody microarray and Recombinant DNA.
Carl A.K. Borrebaeck has included themes like Protein microarray, Molecular biology, Genomic biomarkers, Biomarker and Protein Array Analysis in his Computational biology study.
His Biomarker research incorporates themes from Cancer and Autoimmune pancreatitis, Pancreatitis.
Carl A.K. Borrebaeck works on Antibody which deals in particular with Monoclonal antibody.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
